Centocor ReoPro reduces mortality and MI by 50% in unstable angina PTCA patients -- CAPTURE study.
Executive Summary
CENTOCOR REOPRO REDUCES MORTALITY, MI BY 50% IN PTCA PATIENTS with unstable angina, Maarten Simoons, MD, Erasmus University, Rotterdam, the Netherlands, told the American College of Cardiology annual scientific session March 25 in Orlando. Simoons presented preliminary data from the Chimeric 7E3 Antiplatelet Therapy in Unstable Angina Refractory to Standard Treatment study.